Lamivudine Completed Phase 4 Trials for Lipodystrophies / Metabolic Diseases / Dyslipidemias / Cardiovascular Disease (CVD) / Glucose Metabolism Disorders / Human Immunodeficiency Virus (HIV) Infections Basic Science

IndicationsStatusPurposePhase
CompletedBasic Science4
clinicaltrials.gov IdentifierTitleDrugs
NCT00192621Seronegatives and Metabolic Abnormalities Protocol 2 (SAMA002): Study to Compare the Effect of Kaletra and Combivir® in HIV-Negative Healthy Subjects